About Spectral MD
AI
Spectral MD develops technology using predictive analytics and AI algorithms to help clinicians make more accurate and faster treatment decisions. There are no diagnostic imaging devices that provide clinicians with an objective and immediate assessment of a wound’s healing potential.
Spectral MD’s DeepView® Technology provides an informed solution for clinicians and allows for a clear picture of the wound to be established prior to treatment or other interventions.
DeepView® is a portable imaging platform that allows for immediate wound healing assessment and provides clinicians with physiological information that is not visible to the human eye.
Spectral MD owns its cloud-based data pipeline, from patient data collection to an output that is meaningful to the clinician. This information can be used by physicians to guide therapeutic procedures for the patient.
Leadership Team
Chief Executive Officer, Co-Founder
Wensheng Fan is a Co-Founder and the first employee of Spectral MD. Over the past 11 years he has served as CTO and COO, before becoming the CEO of Spectral MD. He is an executive, entrepreneur, and innovator with over 20 years of experience in natural speech recognition and imaging systems. Mr. Fan held various leadership roles in strategy, engineering, and operations with Sensata Technologies and Philips. He also has a long history of experience in business development and cross-functional team leadership, being a founder and/or early core member of multiple successful start-up companies. Under his leadership, Spectral MD’s DeepView® was granted FDA Breakthrough Device designation and is well on its way to disrupting the field of healthcare and medical technology.
Mr. Fan received his B.S.E.E. degree from Tsinghua University in Beijing, China and M.S.E.E. degree from Northeastern University in Boston.
Chief Operating Officer
Niko Pagoulatos, Ph.D. is a technology executive and innovator with 25+ years of experience in engineering, clinical and business aspects of specialized medical ultrasound imaging. Dr. Pagoulatos is a team-oriented and results-driven leader with extensive experience and a strong track record in building and leading cross-functional teams to successfully commercialize innovative medical technologies with global clinical impact. Prior to joining Spectral MD, Dr. Pagoulatos held multiple executive roles at EchoNous, a global healthcare AI-focused medical ultrasound innovation company. Prior to EchoNous, Dr. Pagoulatos held director and advanced research and development engineering roles at FUJIFILM SonoSite, the world leader in point-of-care ultrasound, DYSIS Medical, a company focused on early detection and diagnosis of cervical disease using biophotonics, and Siemens Healthcare.
Dr. Pagoulatos earned his B.S. in Physics from the University of Athens in Greece and completed his graduate studies at the University of Washington in Seattle, where he earned a M.S. in Bioengineering in addition to a M.S. and Ph.D. in Electrical Engineering.
Mr. Windler brings more than 20 years of Finance and Operations experience and is recognized as a hands-on, forward-thinking executive and business strategist who leverages extensive financial, operations and sales experience to fuel revenue growth, enhance profitability and seamlessly execute organizational turnarounds and transformations. Prior to joining Spectral MD, Mr. Windler served as Senior Finance Leader and Business Finance Transformation Leader at 3M. Prior to its acquisition, Mr. Windler also served as Vice President of Finance for Americas at KCI, an Acelity company.
Mr. Windler holds an MBA, General Management from The Berlin School of Economics & Law & Anglia Ruskin University in Cambrige, U.K. and a BA, Business Administration, Banking Management, Finance & Investments from The Berlin School of Economics and Law.
Chief Financial Officer
Jeffrey Thatcher, Ph.D. serves as the Chief Scientist at Spectral MD. He currently oversees technology and applications research for medical imaging systems. He is a former Howard Hughes Medical Institute (HHMI) undergraduate research fellow, has served as PI on three National Science Foundation (NSF) grants, and is currently the PI of an Health and Human Services Biomedical Advanced Research and Development Authority (HHS/BARDA) government contract to develop an imaging device to assist with burn care.
Dr. Thatcher received a B.S. in molecular biology from Texas Tech University and Ph.D. in biomedical engineering from University of Texas Southwestern Medical Center.
Chief Scientist
Kevin Plant leads Software Engineering at Spectral MD. He currently directs the Application Software and Deep Learning Data Science teams, and drives the medical device product development process. He has spent his career transforming medical research into released medical devices, and specializes in medical device Systems and Software development. Before Spectral MD, he worked in neuro and cardiac implantable research and development with St. Jude Medical and Abbott.
Kevin received a B.S. in Biomedical Engineering from the University of Texas at Austin.
Vice President, Software
Vice President, Production and System Engineering
Louis Percoco is a seasoned engineering leader who brings more than 31 years of experience to the field of Research, Development, and Production. Louis has spent his career developing and manufacturing Electronics, Software, and Hardware benefiting the Medical Device Industry. Recognized as a thought leader in the field of software and electronic controlled medical devices, Louis has led R&D and Production teams in Cardiology, Orthopedic and Spine disciplines.
Mary Regan, Ph.D. serves as VP Clinical Affairs at Spectral MD where she oversees all clinical trials and supports the commercial business operations. Dr. Regan brings over 30 years of clinical experience in wound technology assessment, development, research, and innovation with major industry leaders. Widely renowned in national and international forums as an industry thought leader in wound care, Dr. Regan’s career has been dedicated to improving prevention and management of chronic wounds and clinical research to improve outcomes for all patients with wounds. Dr. Regan has held board positions in the American Association of Wound Care Specialists and National Wound Healing Society.
Dr. Regan received her Masters/B.S Degree in Registered Nursing, Nursing Administration, Nursing Research, and Clinical Nursing from SUNY Upstate Medical University and PH.D. in Nursing Science from the University of Miami.
Vice President, Clinical Affairs
Christine Marks serves as Vice President of Marketing and Commercialization at Spectral MD and brings successful go-to-market experience to the organization. She has over 20 years of marketing and commercialization experience launching innovations globally at medical device and technology companies such as BSN Medical, Lohmann & Raucher, and Monarch Medical Technologies.
Mrs. Marks earned her M.B.A. degree from Wake Forest University and her B.S. degree in Marketing from Appalachian State University.
Vice President, Marketing and
Commercialization
Vince Capone serves as General Counsel and Corporate Secretary at Spectral MD and brings a wealth of experience to the Company. He began his career as a CPA at KPMG, LLP before practicing corporate and securities law. He has over 20 years of broad legal experience, first at Morgan Lewis, LLP, then as a Partner at Reed Smith, LLP and most recently, as General Counsel for a New York-based private equity fund investing in global life sciences and technology companies. Mr. Capone has an extensive background in representing life science and technology companies and he has a proven track record as a business-focused and results-oriented leader in driving corporate growth and development.
Mr. Capone earned both his J.D. and M.B.A. degrees from Temple University and his B.S. degree in Accounting from Pennsylvania State University.
General Counsel and
Corporate Secretary
In the Chief Medical Consultant role, Dr. Carter will be guiding Spectral MD’s clinical direction and ensuring that the company’s technology has a meaningful clinical impact for patients and physicians. Dr. Carter has been practicing burn/trauma medicine for over 12 years and currently serves as the Medical Director for the University Medical Center Burn Center in New Orleans, LA, and on faculty at Louisiana State University Health Sciences Center.
Dr. Carter earned his medical degree from East Tennessee State University in 2005 with honors and practiced general surgery and surgery critical care before specializing in burn treatment. He completed his burn/trauma fellowship at University of North Carolina, Chapel Hill and is board-certified by the American Board of Surgery in Surgery and Surgical Critical Care.
Chief Medical Consultant
Spectral MD
Dallas, Texas, United States
Our headquarters are located in the heart of Uptown in Dallas. A tad north of downtown Dallas and connected by Klyde Warren Park, Uptown is a dynamic district known as a popular destination for residents and visitors alike.
Spectral MD is located within the Chateau Plaza office building on McKinney Avenue, within walking distance to best-in-class restaurants, residences, and retail. We are only five minutes from Dallas Love Field and twenty-five minutes from Dallas/Fort Worth International Airport. Our location also has easy ingress/egress to major freeways: I-35, I-45, US-75, and Dallas North Tollway, with onsite parking.